110818 ⎘
ssRNA viruses negative-sense; Details; Orthomyxoviridae; Influenzavirus A, i.e. influenza A virus; Use of virus, viral particle or viral elements as a vector viral genome or elements thereof as genetic vector
Mutated Influenza Virus, Pharmaceutical Composition, and Use
#2MRNA ENCODING INFLUENZA VIRUS-LIKE PARTICLE
#3ATTENUATED ORTHOMYXOVIRUS-BASED VECTOR PLATFORM
#4RECOMBINANT VIRUS CONTAINING DEGRON, PREPARATION METHOD THEREFOR, AND APPLICATION THEREOF
#5CONSTRUCTION AND APPLICATION OF RECOMBINANT H5N8 SUBTYPE AVIAN INFLUENZA VIRUS CARRYING MAPPLE FLUORESCENCE REPORTER GENE
#6LIMITING VIRAL INFECTION AND REPLICATION IN STEM CELLS
#7COMPOSITIONS AND METHODS FOR THE GENETIC MANIPULATION OF THE INFLUENZA VIRUS
#8INFLUENZA VIRUSES WITH MUTANT PB2 GENE SEGMENT AS LIVE ATTENUATED VACCINES
#9Engineered influenza polynucleotides, viruses, vaccines and methods of making and using the same
#10STRAIN DIS-DERIVED RECOMBINANT VACCINIA VIRUS HAVING NOVEL INFLUENZA VIRUS-DERIVED HEMAGGLUTININ PROTEIN GENE
#11Influenza virus vectors and uses therefor
#12RNA VIRUS VECTORS CARRYING DAI AND RIPK3
#13H5N6 recombinant influenza virus, a composition for preparing the same, and a vaccine composition containing the same
#14Recombinant influenza viruses and constructs and uses thereof
#15NUCLEIC ACID MOLECULES AND DUAL-FUNCTIONAL PEPTIDES HAVING ANTIVIRAL ACTIVITY AND DELIVERY ACTIVITY, COMPOSITIONS AND METHODS THEREOF
#16Influenza virus vectors and uses therefor
#17Influenza viruses with mutant PB2 gene segment as live attenuated vaccines
#18Compositions and methods to increase production
#19Engineered influenza polynucleotides, viruses, vaccines and methods of making and using the same
#20RNA virus vectors carrying DAI and RIPK3
#21Directing Cancer Cells to Self-Destruct Through Vectoring Engineered Viruses
#22Enhanced expression of RNA vectors
#23Influenza virus vector for virotherapy
#24Influenza virus replication for vaccine development
#25COMPUTATIONALLY OPTIMIZED BROADLY REACTIVE ANTIGENS FOR INFLUENZA
#26Recombinant Influenza Viruses for Vaccines and Gene Therapy
#27Attenuated influenza vectors for the prevention and/or treatment of infectious diseases and for the treatment of oncological diseases
#28Influenza virus vectors and uses therefor
#29Recombinant influenza virus vaccines for influenza
#30Recombinant RNA Viruses and Uses Thereof
#31Dual purpose universal influenza vaccine confers protective immunity against anthrax
#32Computationally optimized broadly reactive antigens for influenza
#33Recombinant Influenza Viruses for Vaccines and Gene Therapy
#34Influenza virus vectors and uses therefor
#35Influenza virus replication for vaccine development
#36Chimeric viruses presenting non-native surface proteins and uses thereof
#37Monovalent H5 vaccine
#38Influenza virus recombinant proteins
#39Influenza virus vector for virotherapy
#40Recombinant influenza viruses for vaccines and gene therapy
#41Influenza virus reassortment
#42Influenza viruses with mutant PB2 segment as live attenuated vaccines
#43Recombinant influenza vectors with tandem transcription units
#44Attenuated negative strand viruses with altered interferon antagonist activity for use as vaccines and pharmaceuticals
#45Virus-like particles for treatment of viral infections
#46Reassortant influenza viruses for vaccines
#47Recombinant influenza viruses and constructs and uses thereof
#48Multi plasmid system for the production of influenza virus
#49Replication deficient influenza virus for the expression of heterologous sequences
#50Influenza viruses with mutant PB2 gene segment as live attenuated vaccines
#51Influenza virus recombinant proteins
#52Reassortant influenza B viruses
#53Multi plasmid system for the production of influenza virus
#54Attenuated negative strand viruses with altered interferon antagonist activity for use as vaccines and pharmaceuticals
#55Recombinant influenza viruses and uses thereof
#56Recombinant influenza viruses for vaccines and gene therapy
#57Chimeric viruses presenting non-native surface proteins and uses thereof
#58Helper-free Rescue of Recombinant Negative Strand RNA Virus Systems
#59INFLUENZA HEMAGGLUTININ AND NEURAMINIDASE VARIANTS
#60Multi plasmid system for the production of influenza virus
#61Recombinant influenza vectors with tandem transcription units
#62RECOMBINANT INFLUENZA VIRUSES FOR VACCINES AND GENE THERAPY
#63Influenza hemagglutinin and neuraminidase variants
#64Virus-like particles for treatment of viral infections
#65NOVEL METHODS AND INTERFERON DEFICIENT SUBSTRATES FOR THE PROPAGATION OF VIRUSES
#66ATTENUATED NEGATIVE STRAND VIRUSES WITH ALTERED INTERFERON ANTAGONIST ACTIVITY FOR USE AS VACCINES AND PHARMACEUTICALS
#67REPLICATION DEFICIENT INFLUENZA VIRUS FOR THE EXPRESSION OF HETEROLOGOUS SEQUENCES
#68LINEAR EXPRESSION CONSTRUCTS FOR PRODUCTION OF INFLUENZA VIRUS PARTICLES
#69Recombinant influenza viruses expressing tumor-associated antigens as antitumor agents
#70Signal for packaging of influenza virus vectors
#71Multi plasmid system for the production of influenza virus
#72RECOMBINANT INFLUENZA VIRUSES FOR VACCINES AND GENE THERAPY
#73Methods for the propagation of modified influenza viruses in embryonated eggs
#74Influenza Hemagglutinin And Neuraminidase Variants
#75Method for producing temperature sensitive influenza A viruses
#76Recombinant negative strand RNA virus expression systems and vaccines
#77Attenuated negative strand viruses with altered interferon antagonist activity for use as vaccines and pharmaceuticals
#78Defective Influenza Virus Particles
#79Signal for packaging of influenza virus vector
#80Influenza hemagglutinin and neuraminidase variants
#81Recombinant influenza vectors with tandem transcription units
#82System producing infectious recombinant influenza virus
#83Recombinant influenza viruses for vaccines and gene therapy
#84Methods of use of viral vectors to deliver antigen to dendritic cells
#85Multi plasmid system for the production of influenza virus
#86Methods and interferon deficient substrates for the propagation of viruses
#87Influenza hemagglutinin and neuraminidase variants
#88Recombinant influenza vectors with a polII promoter and ribozymes for vaccines and gene therapy
#89Recombinant negative strand RNA virus expression systems and vaccines
#90High titer recombinant influenza viruses for vaccines and gene therapy